Ameridose, LLC. is a medical manufacturer based in Westborough, Massachusetts. The company was founded, along with its sister company New England Compounding Center, by brothers-in-law Greg Conigliaro and Barry Cadden.[5] The owners of Ameridose are Carla R. Conigliaro, Barry J. Cadden, Lisa M. Conigliaro and Gregory A. Conigliaro.[6]
| Industry | Pharmaceutical |
|---|---|
| Founded | 2006 |
| Headquarters | Westborough, Massachusetts U.S. |
Key people | Gregory Conigliaro, owner and director Barry Cadden, owner,[1][2][3] Douglas Conigliaro, anesthesiologist and president of Medical Sales Management Carla Conigliaro, shareholder and director; wife of Douglas Conigliaro Glenn Adam Chin, supervisory pharmacist[4] |
| Products | pharmaceuticals |
| Revenue | 300 million |
Number of employees | 1000+ |
| Website | ameridose.com |
History
editBrothers-in-law Greg Conigliaro and Barry Cadden established Ameridose to be a large manufacturer of prescription medications for use in hospitals. The original location of the company's plant was in Framingham, Massachusetts next to its sister-companies New England Compounding Center and Medical Sales Management. In 2009, they purchased and started operations at two new locations, 205 and 203 Flanders Road in nearby Westborough,[7] to accommodate the steady growth of the company. Ameridose would eventually employ over 1000 people and report annual revenues of 300 million.
NECC Affiliation
editAmeridose's sister-company, New England Compounding Center (NECC), was implicated as the source of a nationwide fungal meningitis outbreak of 2012.[8] It was found that tainted batches of the steroid methylprednisolone acetate caused hundreds of cases of fungal meningitis.[9] Sixty-four deaths have been attributed to the tainted steroids.
Although Ameridose was not the source of the outbreak, the company was largely impacted by its affiliation with NECC. Due to pressure from the state and the U.S. Food and Drug Administration (FDA) because of growing concern of their association with NECC, the company recalled all of its products and shut down operations in October 2012. In early November that year, Ameridose laid off 650 employees working in its Westborough facilities.[10]
The FDA began investigating Ameridose's facilities in October 2012. There were fifteen concerning observations that they made during the investigations. These include the following:
- A bird was observed flying around inside the building in an area where finished drugs are stored
- Insects were found in an area where finished drugs are stored
- Gaps were observed underneath doors and "pass-through boxes"
- Thick residues of orange, brown, and green were observed in several hoods where drugs are made
- Drugs were shipped out before sterility tests were complete
- Ameridose failed to investigate complaints made by customers about its products
On October 12, 2012, The New York Times published an article in which they interviewed employees from both NECC and Ameridose.[11] Some stated that the company was run well and seemed safe. Several others voiced their concerns with the companies. Many employees interviewed believed that Ameridose emphasized quantity and speed instead of quality and safety. The article also stated that in 2008 an inspector from the FDA found that the firm did not use adequate potency testing on their products.
In December 2012, WFXT reporter Mike Beaudet interviewed a former Ameridose employee. She said employees would often see bugs and birds inside the company's buildings.[12] She also claimed that she witnessed company supervisors attempting to cover up their tracks for taking shortcuts when they learned that the FDA was going to inspect their facilities.
References
edit- ^ Tavernise, Abby Goodnough, Sabrina; Pollack, Andrew (24 October 2012). "With Meningitis Outbreak, a Spotlight on Family Behind Compounding Pharmacy". The New York Times – via NYTimes.com.
{{cite news}}: CS1 maint: multiple names: authors list (link) - ^ Shira Schoenberg (December 17, 2014). "Fourteen arrested, including owners, for meningitis outbreak tied to New England Compounding Center". MassLive.
Those arrested include: Owner, president and head pharmacist Barry Cadden; owner and director Greg Conigliaro; national sales director Robert Ronzio; shareholder and director Carla Conigliaro; Conigliaro's husband Doug Conigliaro, who was president of Medical Sales Management, which provided sales and administrative services to New England Compounding Pharmacy
- ^ Laura Strickler (October 16, 2012). "Inside the New England Compounding Center". CBS News. Retrieved December 19, 2014.
The New England Compounding Center is a family-owned and operated pharmacy based in Framingham, Mass. It is owned by Barry J. Cadden, his wife, Lisa Cadden and her brother Gregory Conigliaro, according to public records from the Secretary of Commonwealth.
- ^ "NECC sterility pharmacist arrested". The Tennessean.
- ^ Weise, Elizabeth. "FDA Finds Contamination Issues at Ameridose." USA Today. Gannett, 13 Nov. 2012.
- ^ Establishment Inspection Report, Food and Drug Administration
- ^ Krantz, Laura (October 11, 2012). "Westborough firm agrees to temporary shutdown in outbreak". The Patriot Ledger.
- ^ Sampson, Zachary T. "New England Compounding Center, Blamed for Meningitis Outbreak, Files for Bankruptcy." Boston.com. The New York Times, 21 Dec. 2012.
- ^ LeBlanc, Steve. "Governor Proposes New Compounding Pharmacy Rules." USA Today. Gannett, 04 Jan. 2013. Web. 04 Jan. 2013.
- ^ Lazar, Kay, and Todd Wallack. "Ameridose, Sister Company to Pharmacy Linked to Fungal Meningitis Outbreak, Laying off Hundreds." Boston.com. The New York Times, 08 Nov. 2012.
- ^ Tavernise, Sabrina, and Andrew Pollack. "Ex-Workers Cite Safety Concerns At a Drug Firm." The New York Times. The New York Times, 13 Oct. 2012. Web. 04 Jan. 2013.
- ^ Beaudet, Mike. "Former Ameridose Worker Discusses What She Calls Potentially Deadly Safety Hazards." Former Ameridose Worker Discusses What She Calls Potentially - Boston News, Weather, Sports | FOX 25 | MyFoxBoston. FOX25 Boston, 14 Dec. 2012.